Adjuvante Therapie der Atopischen Dermatitis - Wohlrab-net.de

110 Triclosan
_____________________________________________________________________________________
- Stone GW, Zhang Q, Castillo R, Doppalapudi VR, Bueno AR, Lee JY, Li
Q, Sergeeva M, Khambatta G, Georgopapadakou NH: Mechanism of
Action of NB2001 and NB2030, Novel Antibacterial Agents Activated by
beta-Lactamases. Antimicrob Agents Chemother. 2004 Feb;48(2):477-83
- Sivaraman S, Sullivan TJ, Johnson F, Novichenok P, Cui G, Simmerling C,
Tonge PJ: Inhibition of the Bacterial Enoyl Reductase FabI by Triclosan: A
Structure-Reactivity Analysis of FabI Inhibition by Triclosan Analogues. J
Med Chem. 2004 Jan 29;47(3):509-18
- Guillen J, Bernabeu A, Shapiro S, Villalain J: Location and orientation of
Triclosan in phospholipid model membranes. Eur Biophys J. 2004 Jan 9
- Rao SP, Surolia A, Surolia N.: Triclosan: a shot in the arm for antimalarial
chemotherapy. Mol Cell Biochem. 2003 Nov;253(1-2):55-63
- Lee TW, Kim JC, Hwang SJ: Hydrogel patches containing Triclosan for
acne treatment. Eur J Pharm Biopharm. 2003 Nov;56(3):407-12
- Regos J, Zak O, Solf R, Vischer WA, Weirich EG: Antimicrobial spectrum
of triclosan, a broad-spectrum antimicrobial agent for topical application. II.
Comparison with some other antimicrobial agents. Dermatologica.
1979;158(1):72-9
- Gloor M, Thoma K, Fluhr J: Dermatologische Externatherapie. Springer-
Verlag Berlin, 2000
- Fachinfo Sicorten Plus Creme, Stand 10/2000
____________________________________________________________________________
Wohlrab J (ed.): Adjuvante Therapie der Atopischen Dermatitis
In: Trends Clin Exp Dermatol, Aachen, Shaker, 2005, vol 4